Back to Acceleration Radar
HLFHerbalife Nutrition Ltd
Health Care · Other Pharmaceuticals · Small
$13.39−2.83%
As of 23 Oct 2026Mkt cap $1.3B
Stage 13
WATCH
Fundamentals
43.2/75
Technical
6.7/15
Independent
50.0/90
GCAE viewbusiness is credible but technical recovery is not yet actionable
Price
- 1M
- +9.7%
- 3M
- +9.9%
- 6M
- −19.2%
- 1Y
- +53.0%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 8.6xHist median 5.0x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 4.3x
- FCF yield
- 23.2%
Quality
- ROIC
- 34.6%
- Operating margin
- 7.7%
- FCF margin
- 5.0%
- Current ratio
- 1.1x
Growth
- Revenue growth
- +0.9%Latest FY YoY
- Revenue CAGR
- −3.5%
- EPS CAGR
- −14.6%
- FCF CAGR
- −4.9%
Capital
- Share-count trend
- +1.7%3Y annualised
- Net debt
- $1.7B5.1x OCF
Annual trend
- CAGR 2021–2025
- −3.5%
- Latest · 2025
- $5B
- YoY
- +0.9%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- FUNDAMENTAL DECELERATION
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
business is credible but technical recovery is not yet actionable
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-02
More details & evidence
Production decision
- Stage 13
- WATCH
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded